Fycompa
These highlights do not include all the information needed to use FYCOMPA safely and effectively. See full prescribing information for FYCOMPA. FYCOMPA(perampanel) tablets, for oral use, CIIIFYCOMPA (perampanel) oral suspension, CIIIInitial U.S. Approval: 2012
ec812ea3-de3a-4271-957c-db8f692d1ae3
HUMAN PRESCRIPTION DRUG LABEL
Jan 5, 2024
Catalyst Pharmaceuticals, Inc.
DUNS: 053742248
Products 7
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
perampanel
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (11)
perampanel
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (10)
perampanel
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (12)
perampanel
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (10)
perampanel
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (12)
perampanel
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (11)
perampanel
Product Details
FDA regulatory identification and product classification information